glp 1 heart disease Effects of GLP-1 Receptor Agonists in Failure Patients GLP-1 receptor agonists (GLP-1RAs): cardiovascular

( 10.1126/scitranslmed.3007218) [DOI] [PubMed] [Google Scholar] Finan B, Yang B, Ottaway N, Smiley DL, Ma T, Clemmensen C, Chabenne J, Zhang L, Habegger KM, Fischer K, et al

It is worth noting that the use of semaglutide for patients without diabetes increased by over 256% between 2018 and 2022

Oral Obesity Drugs Market is evolving from its status as a niche weight loss drugs market into one that is characterized by a high-value chronic metabolic disease treatment market

At present, clinical treatment is mainly through restricting the patients diet and regulating blood sugar, strengthening daily exercise and supplementing calcium and vitamins, and using bone formation promoters and bone loss inhibitors for comprehensive treatment